Delivery Order SPE2DB20D2104-SPE2DB25FMYHS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,010.72 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count package). This competitive award, with no set-aside designation, utilizes firm fixed pricing and calls for performance completion by August 15, 2025. AmerisourceBergen Drug Corp will fulfill this order from its Conshohocken, Pennsylvania facility, where the company maintains its corporate office operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,254.60 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on August 13, 2025, with completion targeted for August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $26,128.50 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This non-set-aside, firm fixed-price delivery order was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement fulfilling the Defense Health...
- The Defense Logistics Agency awarded a delivery order valued at $2,175.66 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (quantity: 8 units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a $4,771.95 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on July 29, 2025, with completion scheduled for July 30, 2025. This non-competitive delivery order represents a firm fixed-price transaction for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a $5,299.78 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,449.22 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count). The order is structured as a firm fixed price delivery order with completion scheduled for July 28, 2025, and represents a non-competitive award under an open competition model. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $15,976.54 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). The contract, which is non-set-aside and competitively awarded, carries a firm fixed price and is scheduled for completion by July 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count packages) with a ceiling value of $18,152.90. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through the open market. The order is scheduled for completion by August 15, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $7,797.87 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The contract is scheduled for completion by July 23, 2025, reflecting the expedited nature of this pharmaceutical procurement. This...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYHSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,245.81 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The award reflects AmerisourceBergen Drug Corp's demonstrated capability to meet federal procurement requirements through open competition and its role as a primary vendor within the DLA's pharmaceutical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/20/25 |